Logo image of IR

INGERSOLL-RAND INC (IR) Stock Fundamental Analysis

USA - NYSE:IR - US45687V1061 - Common Stock

81.255 USD
+2.25 (+2.85%)
Last: 9/18/2025, 3:27:59 PM
Fundamental Rating

5

IR gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 128 industry peers in the Machinery industry. IR has an average financial health and profitability rating. While showing a medium growth rate, IR is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

IR had positive earnings in the past year.
In the past year IR had a positive cash flow from operations.
Of the past 5 years IR 4 years were profitable.
Each year in the past 5 years IR had a positive operating cash flow.
IR Yearly Net Income VS EBIT VS OCF VS FCFIR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B

1.2 Ratios

IR's Return On Assets of 2.87% is in line compared to the rest of the industry. IR outperforms 44.53% of its industry peers.
IR's Return On Equity of 5.14% is on the low side compared to the rest of the industry. IR is outperformed by 60.94% of its industry peers.
IR has a Return On Invested Capital of 6.91%. This is comparable to the rest of the industry: IR outperforms 52.34% of its industry peers.
IR had an Average Return On Invested Capital over the past 3 years of 6.33%. This is below the industry average of 10.02%.
The 3 year average ROIC (6.33%) for IR is below the current ROIC(6.91%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 2.87%
ROE 5.14%
ROIC 6.91%
ROA(3y)4.58%
ROA(5y)3.45%
ROE(3y)7.59%
ROE(5y)5.73%
ROIC(3y)6.33%
ROIC(5y)4.79%
IR Yearly ROA, ROE, ROICIR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60 -80

1.3 Margins

IR's Profit Margin of 7.04% is in line compared to the rest of the industry. IR outperforms 57.03% of its industry peers.
IR's Profit Margin has improved in the last couple of years.
With an excellent Operating Margin value of 19.82%, IR belongs to the best of the industry, outperforming 88.28% of the companies in the same industry.
IR's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 43.74%, IR is in the better half of the industry, outperforming 79.69% of the companies in the same industry.
IR's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 19.82%
PM (TTM) 7.04%
GM 43.74%
OM growth 3Y18.5%
OM growth 5Y9.27%
PM growth 3Y2.02%
PM growth 5Y8.01%
GM growth 3Y4.32%
GM growth 5Y2.58%
IR Yearly Profit, Operating, Gross MarginsIR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40

6

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so IR is destroying value.
The number of shares outstanding for IR remains at a similar level compared to 1 year ago.
IR has more shares outstanding than it did 5 years ago.
The debt/assets ratio for IR is higher compared to a year ago.
IR Yearly Shares OutstandingIR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M
IR Yearly Total Debt VS Total AssetsIR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

IR has an Altman-Z score of 3.39. This indicates that IR is financially healthy and has little risk of bankruptcy at the moment.
IR has a Altman-Z score of 3.39. This is in the better half of the industry: IR outperforms 60.16% of its industry peers.
The Debt to FCF ratio of IR is 3.68, which is a good value as it means it would take IR, 3.68 years of fcf income to pay off all of its debts.
IR's Debt to FCF ratio of 3.68 is fine compared to the rest of the industry. IR outperforms 60.16% of its industry peers.
A Debt/Equity ratio of 0.47 indicates that IR is not too dependend on debt financing.
IR has a Debt to Equity ratio of 0.47. This is comparable to the rest of the industry: IR outperforms 46.09% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF 3.68
Altman-Z 3.39
ROIC/WACC0.7
WACC9.8%
IR Yearly LT Debt VS Equity VS FCFIR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.3 Liquidity

A Current Ratio of 2.29 indicates that IR has no problem at all paying its short term obligations.
With a Current ratio value of 2.29, IR perfoms like the industry average, outperforming 59.38% of the companies in the same industry.
A Quick Ratio of 1.63 indicates that IR should not have too much problems paying its short term obligations.
IR has a Quick ratio of 1.63. This is in the better half of the industry: IR outperforms 70.31% of its industry peers.
Industry RankSector Rank
Current Ratio 2.29
Quick Ratio 1.63
IR Yearly Current Assets VS Current LiabilitesIR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

5

3. Growth

3.1 Past

The earnings per share for IR have decreased by -1.23% in the last year.
IR shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 15.65% yearly.
Looking at the last year, IR shows a small growth in Revenue. The Revenue has grown by 4.67% in the last year.
IR shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 29.10% yearly.
EPS 1Y (TTM)-1.23%
EPS 3Y15.06%
EPS 5Y15.65%
EPS Q2Q%-3.61%
Revenue 1Y (TTM)4.67%
Revenue growth 3Y11.98%
Revenue growth 5Y29.1%
Sales Q2Q%4.58%

3.2 Future

Based on estimates for the next years, IR will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.24% on average per year.
Based on estimates for the next years, IR will show a small growth in Revenue. The Revenue will grow by 6.43% on average per year.
EPS Next Y6.16%
EPS Next 2Y7.97%
EPS Next 3Y8.26%
EPS Next 5Y10.24%
Revenue Next Year4.86%
Revenue Next 2Y5.03%
Revenue Next 3Y5.12%
Revenue Next 5Y6.43%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
IR Yearly Revenue VS EstimatesIR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2B 4B 6B 8B 10B
IR Yearly EPS VS EstimatesIR Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1 2 3 4 5

2

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 25.39 indicates a quite expensive valuation of IR.
IR's Price/Earnings is on the same level as the industry average.
When comparing the Price/Earnings ratio of IR to the average of the S&P500 Index (27.20), we can say IR is valued inline with the index average.
With a Price/Forward Earnings ratio of 21.19, IR is valued on the expensive side.
Compared to the rest of the industry, the Price/Forward Earnings ratio of IR is on the same level as its industry peers.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.70, IR is valued at the same level.
Industry RankSector Rank
PE 25.39
Fwd PE 21.19
IR Price Earnings VS Forward Price EarningsIR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as IR.
IR's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 24.87
EV/EBITDA 17.9
IR Per share dataIR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The decent profitability rating of IR may justify a higher PE ratio.
PEG (NY)4.12
PEG (5Y)1.62
EPS Next 2Y7.97%
EPS Next 3Y8.26%

3

5. Dividend

5.1 Amount

IR has a yearly dividend return of 0.10%, which is pretty low.
IR's Dividend Yield is comparable with the industry average which is at 1.74.
Compared to an average S&P500 Dividend Yield of 2.38, IR's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.1%

5.2 History

IR has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
IR Yearly Dividends per shareIR Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2021 2022 2023 2024 2025 0.5 1 1.5 2

5.3 Sustainability

IR pays out 6.23% of its income as dividend. This is a sustainable payout ratio.
DP6.23%
EPS Next 2Y7.97%
EPS Next 3Y8.26%
IR Yearly Income VS Free CF VS DividendIR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B
IR Dividend Payout.IR Dividend Payout, showing the Payout Ratio.IR Dividend Payout.PayoutRetained Earnings

INGERSOLL-RAND INC

NYSE:IR (9/18/2025, 3:27:59 PM)

81.255

+2.25 (+2.85%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)07-31 2025-07-31/amc
Earnings (Next)10-29 2025-10-29/amc
Inst Owners100.59%
Inst Owner Change-3.83%
Ins Owners0.17%
Ins Owner Change-0.68%
Market Cap32.29B
Analysts76.8
Price Target91.95 (13.16%)
Short Float %3.12%
Short Ratio4.02
Dividend
Industry RankSector Rank
Dividend Yield 0.1%
Yearly Dividend0.08
Dividend Growth(5Y)N/A
DP6.23%
Div Incr Years0
Div Non Decr Years0
Ex-Date08-14 2025-08-14 (0.02)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-3.64%
Min EPS beat(2)-4.75%
Max EPS beat(2)-2.53%
EPS beat(4)1
Avg EPS beat(4)-2.56%
Min EPS beat(4)-4.75%
Max EPS beat(4)0.25%
EPS beat(8)5
Avg EPS beat(8)2.46%
EPS beat(12)9
Avg EPS beat(12)5.38%
EPS beat(16)13
Avg EPS beat(16)6.25%
Revenue beat(2)0
Avg Revenue beat(2)-2.12%
Min Revenue beat(2)-3.44%
Max Revenue beat(2)-0.79%
Revenue beat(4)0
Avg Revenue beat(4)-2.79%
Min Revenue beat(4)-3.58%
Max Revenue beat(4)-0.79%
Revenue beat(8)1
Avg Revenue beat(8)-2.37%
Revenue beat(12)5
Avg Revenue beat(12)-0.38%
Revenue beat(16)8
Avg Revenue beat(16)-0.35%
PT rev (1m)-0.71%
PT rev (3m)0.59%
EPS NQ rev (1m)-0.79%
EPS NQ rev (3m)-3.1%
EPS NY rev (1m)1.38%
EPS NY rev (3m)1.37%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.88%
Revenue NY rev (1m)1.19%
Revenue NY rev (3m)1.28%
Valuation
Industry RankSector Rank
PE 25.39
Fwd PE 21.19
P/S 4.39
P/FCF 24.87
P/OCF 22.55
P/B 3.2
P/tB N/A
EV/EBITDA 17.9
EPS(TTM)3.2
EY3.94%
EPS(NY)3.84
Fwd EY4.72%
FCF(TTM)3.27
FCFY4.02%
OCF(TTM)3.6
OCFY4.44%
SpS18.53
BVpS25.38
TBVpS-6.35
PEG (NY)4.12
PEG (5Y)1.62
Profitability
Industry RankSector Rank
ROA 2.87%
ROE 5.14%
ROCE 9%
ROIC 6.91%
ROICexc 7.51%
ROICexgc 48.63%
OM 19.82%
PM (TTM) 7.04%
GM 43.74%
FCFM 17.63%
ROA(3y)4.58%
ROA(5y)3.45%
ROE(3y)7.59%
ROE(5y)5.73%
ROIC(3y)6.33%
ROIC(5y)4.79%
ROICexc(3y)7.12%
ROICexc(5y)5.43%
ROICexgc(3y)46.29%
ROICexgc(5y)35.83%
ROCE(3y)8.25%
ROCE(5y)6.23%
ROICexcg growth 3Y22.68%
ROICexcg growth 5Y21.38%
ROICexc growth 3Y22.68%
ROICexc growth 5Y6.23%
OM growth 3Y18.5%
OM growth 5Y9.27%
PM growth 3Y2.02%
PM growth 5Y8.01%
GM growth 3Y4.32%
GM growth 5Y2.58%
F-Score8
Asset Turnover0.41
Health
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF 3.68
Debt/EBITDA 2.45
Cap/Depr 27.44%
Cap/Sales 1.82%
Interest Coverage 5.29
Cash Conversion 73.52%
Profit Quality 250.44%
Current Ratio 2.29
Quick Ratio 1.63
Altman-Z 3.39
F-Score8
WACC9.8%
ROIC/WACC0.7
Cap/Depr(3y)25.25%
Cap/Depr(5y)20.22%
Cap/Sales(3y)1.73%
Cap/Sales(5y)1.5%
Profit Quality(3y)146.25%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1.23%
EPS 3Y15.06%
EPS 5Y15.65%
EPS Q2Q%-3.61%
EPS Next Y6.16%
EPS Next 2Y7.97%
EPS Next 3Y8.26%
EPS Next 5Y10.24%
Revenue 1Y (TTM)4.67%
Revenue growth 3Y11.98%
Revenue growth 5Y29.1%
Sales Q2Q%4.58%
Revenue Next Year4.86%
Revenue Next 2Y5.03%
Revenue Next 3Y5.12%
Revenue Next 5Y6.43%
EBIT growth 1Y6.5%
EBIT growth 3Y32.7%
EBIT growth 5Y41.07%
EBIT Next Year16.88%
EBIT Next 3Y10.46%
EBIT Next 5Y10.72%
FCF growth 1Y40.3%
FCF growth 3Y31.28%
FCF growth 5Y32.51%
OCF growth 1Y39.34%
OCF growth 3Y31.41%
OCF growth 5Y32.4%